癌症相关的静脉血栓栓塞在住院患者中,固体和血液恶性瘤:一个全面的国家研究
Zaid Khamis1, Ghada Araji1, Ibrahim Al Saidi1
1Department of Internal Medicine, Northwell Health/Staten Island University Hospital, Staten Island, NY 10305, USA.
Cancers
|March 13, 2025
概括
癌症患者的静脉血栓塞栓症 (VTE) 风险因人口统计和癌症类型而异. 女性,黑人患者和那些患有固体瘤的人面临更高的VTE发病率,需要有针对性的预防策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 流行病学 流行病学
背景情况:
- 静脉血栓栓塞 (VTE) 是癌症患者死亡的主要原因.
- 了解人口和癌症类型对静脉瘤风险的影响对于预防至关重要.
研究的目的:
- 在一大群癌症患者中调查静脉瘤发病率.
- 根据性别,种族和恶性瘤类型 (固体与血液) 来分析静脉瘤风险.
主要方法:
- 使用了来自国家住院样本 (NIS) 数据库的数据.
- 鉴定了患有急性静脉瘤的癌症患者,按固体和血液恶性瘤分层分类.
- 用于统计分析的员工倾向得分匹配和后勤回归.
主要成果:
- 在1,233,832名癌症患者中,5.1%被诊断患有VTE.
- 女性 (5.5%) 和黑人患者 (6.4%) 的VTE发病率高于男性 (4.8%) 和白人患者 (5%).
- 固体恶性瘤 (5.4%) 的发生率高于血液恶性瘤 (4.1%).
结论:
- 静脉瘤风险受患者人口统计和癌症类型的影响.
- 确定了高风险群体:女性,黑人患者和患有固体瘤的人.
- 强调在瘤学中需要个性化VTE预防策略.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
Esophageal Varices-II: Clinical Features and Management
33
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
33
Bone Marrow Sampling and Transplants
269
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
269
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K


